These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
654 related articles for article (PubMed ID: 7490878)
1. Incidence of apoptosis, cell proliferation and bcl-2 expression in transitional cell carcinoma of the bladder: association with tumor progression. King ED; Matteson J; Jacobs SC; Kyprianou N J Urol; 1996 Jan; 155(1):316-20. PubMed ID: 7490878 [TBL] [Abstract][Full Text] [Related]
2. Bilharzial related, organ confined, muscle invasive bladder cancer: prognostic value of apoptosis markers, proliferation markers, p53, E-cadherin, epidermal growth factor receptor and c-erbB-2. Haitel A; Posch B; El-Baz M; Mokhtar AA; Susani M; Ghoneim MA; Marberger M J Urol; 2001 May; 165(5):1481-7. PubMed ID: 11342901 [TBL] [Abstract][Full Text] [Related]
4. [Expression of Caspase-3 and Bcl-2 in bladder transitional carcinoma and their significance]. Shen HW; Yi L; Wang XM; Yao MJ; Deng JW; Fang JZ; Li MN Ai Zheng; 2004 Feb; 23(2):181-4. PubMed ID: 14960240 [TBL] [Abstract][Full Text] [Related]
5. [Expression of bcl-2 and p16 in transitional cell carcinoma of urinary bladder]. Leng J; Zhang Y; Yao X; Wen K Zhonghua Wai Ke Za Zhi; 2000 Jan; 38(1):40-3. PubMed ID: 11831985 [TBL] [Abstract][Full Text] [Related]
6. Expression of cyclooxygenase-2 in normal urothelium, and superficial and advanced transitional cell carcinoma of bladder. Margulis V; Shariat SF; Ashfaq R; Thompson M; Sagalowsky AI; Hsieh JT; Lotan Y J Urol; 2007 Mar; 177(3):1163-8. PubMed ID: 17296438 [TBL] [Abstract][Full Text] [Related]
7. Spontaneous apoptosis in laryngeal squamous cell carcinoma is independent of bcl-2 and bax protein expression. Jäckel MC; Dorudian MA; Marx D; Brinck U; Schauer A; Steiner W Cancer; 1999 Feb; 85(3):591-9. PubMed ID: 10091732 [TBL] [Abstract][Full Text] [Related]
8. Expression of bcl-2 and bcl-X in bladder cancer. Kirsh EJ; Baunoch DA; Stadler WM J Urol; 1998 Apr; 159(4):1348-53. PubMed ID: 9507882 [TBL] [Abstract][Full Text] [Related]
9. [The detection of protein expression of clusterin and Ki-67 and the status of cell apoptosis in bladder transitional cell carcinoma]. Chen W; Xie D; Luo JH; Wang CX; Tao Y; Zheng KL; Mei H Zhonghua Wai Ke Za Zhi; 2006 Jan; 44(2):111-4. PubMed ID: 16620672 [TBL] [Abstract][Full Text] [Related]
10. Abnormal bcl-2 and pRb expression are independent correlates of radiation response in muscle-invasive bladder cancer. Pollack A; Wu CS; Czerniak B; Zagars GK; Benedict WF; McDonnell TJ Clin Cancer Res; 1997 Oct; 3(10):1823-9. PubMed ID: 9815569 [TBL] [Abstract][Full Text] [Related]
11. Novel p53/p130 axis in bladder tumors. Mudryj M; Reay E; Beckett L; Dandekar S; deVere White R; Gandour-Edwards R Urology; 2007 Sep; 70(3):608-12. PubMed ID: 17905135 [TBL] [Abstract][Full Text] [Related]
12. DNA content and proliferation activity in superficial transitional cell carcinoma of the bladder. Pantazopoulos D; Ioakim-Liossi A; Karakitsos P; Aroni K; Kakoliris S; Kanavaros P; Kyrkou KA Anticancer Res; 1997; 17(1B):781-6. PubMed ID: 9066620 [TBL] [Abstract][Full Text] [Related]
13. Response of bladder carcinoma cells to TRAIL and antisense oligonucleotide, Bcl-2 or clusterin treatments. Sun B; Moibi JA; Mak A; Xiao Z; Roa W; Moore RB J Urol; 2009 Mar; 181(3):1361-71. PubMed ID: 19157446 [TBL] [Abstract][Full Text] [Related]
14. The expression of p53 and bcl-2 in superficial bladder transitional cell carcinoma and its role in the outcome of postoperative intravesical chemotherapy. Tzai TS; Chow NH; Lin JS; Yang WH; Tong YC Anticancer Res; 1998; 18(6B):4717-21. PubMed ID: 9891547 [TBL] [Abstract][Full Text] [Related]
15. Urinary and tissue levels of scatter factor in transitional cell carcinoma of bladder. Rosen EM; Joseph A; Jin L; Yao Y; Chau MH; Fuchs A; Gomella L; Hastings H; Goldberg ID; Weiss GH J Urol; 1997 Jan; 157(1):72-8. PubMed ID: 8976219 [TBL] [Abstract][Full Text] [Related]
16. Apoptosis and apoptosis-related factors Bcl-2, Bax, tumor necrosis factor-alpha, and NF-kappaB in human endometrial hyperplasia and carcinoma. Vaskivuo TE; Stenbäck F; Tapanainen JS Cancer; 2002 Oct; 95(7):1463-71. PubMed ID: 12237915 [TBL] [Abstract][Full Text] [Related]
17. An immunohistochemical and prognostic evaluation of cathepsin D expression in 105 bladder carcinomas. Dickinson AJ; Fox SB; Newcomb PV; Persad RA; Sibley GN; Harris AL J Urol; 1995 Jul; 154(1):237-41. PubMed ID: 7776437 [TBL] [Abstract][Full Text] [Related]
18. Evaluation of hypoxia-inducible factor 1alpha overexpression as a predictor of tumour recurrence and progression in superficial urothelial bladder carcinoma. Theodoropoulos VE; Lazaris AC; Kastriotis I; Spiliadi C; Theodoropoulos GE; Tsoukala V; Patsouris E; Sofras F BJU Int; 2005 Feb; 95(3):425-31. PubMed ID: 15679808 [TBL] [Abstract][Full Text] [Related]
19. Overexpression of BCL-x protein in primary breast cancer is associated with high tumor grade and nodal metastases. Olopade OI; Adeyanju MO; Safa AR; Hagos F; Mick R; Thompson CB; Recant WM Cancer J Sci Am; 1997; 3(4):230-7. PubMed ID: 9263629 [TBL] [Abstract][Full Text] [Related]
20. [The clinico-pathological significance of protein expression of PAK1 in bladder transitional cell carcinoma]. Zhang YH; Xie D; Luo JH; Chen W; Chen LW; Xu QC; Liu GY; Ma HB; Lin WQ Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(38):2710-3. PubMed ID: 18167251 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]